Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Objective evaluation of pasireotide effects on gastrointestinal transit and rectal wall properties in carcinoid diarrhea
2012-003939-27Phase 2Completed
- Sponsor
- Klaus Krogh
- Start
- Feb 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in apudoma (NET) and Carcinoid Syndrome (CS) comparing Pasireotide with Placebo (2 arms). Primary endpoints: Primary and Primary (between-group comparison). Started Feb 2013; status: completed.
02
Drugs
pasireotide LAR
03
Conditions
apudoma (NET)Carcinoid Syndrome (CS)
Beyond the preview
Go deeper on 2012-003939-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003939-27.